In last week’s policy-focused Bulletin (149) we covered the publication of Transform Drug Policy Foundation’s 124-page guide, How to Regulate Psychedelics. Shortly after its publication,
This issue’s contents: California: TREAT Retreats and Wiener Regroups, While Psilocybin Decrim. Initiative Continues Collecting Signatures Veterans’ Affairs Subcommittee on Health Discusses Psychedelics Canadian Senate’s
Written by Psychedelic Alpha Medical Advisor Michael Haichin, PharmD, and Josh Hardman as part of the Pα+ Library. As we look ahead to potential approvals
*** To start off the meeting of Public Health and Health Equity, Sam Bahrami introduced Lorey Bratten, the newly-hired program director for the NMAB. DOR
Late last month, psychedelic venture studio Beckley Waves announced that it had acquired Nue Life, an at-home ketamine provider. (Nue Life was acquired by NueCo
This October, we saw two significant psychedelic studies being published that were previously released as pre-prints. The first is concerned with the extended DMT trial
This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in
I want to start by thanking you all for your ongoing readership. Every time I pen something and send it out into the ether I
*** Listening Session #5 – Cultivation and Manufacturing Practices Part 1 Following formalities, Dominique Mendiola gave an overview of DOR’s statutory requirements under Title 44
On Saturday October 7th California’s Governor, Gavin Newsom, returned Senate Bill 58 to the Senate without his signature, effectively vetoing it. As a reminder, SB